L&K Biomed Ltd.

A156100

KR7156100000

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
10,090 ^KRW	+0.20%		+3.81%	-0.88%

05-09	L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from a group of investors	CI
05-07	L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors	CI

L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2018.

May 30, 2018

On May 31, 2018, the company announced that it has extended its plan duration till November 30, 2018.

Latest news about L&K Biomed Ltd.

L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from a group of investors	05-08	CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from a group of investors	05-06	CI
RootLoc Co., Ltd. announced that it has received KRW 3.686515722 billion in funding from L&K Biomed Ltd.	10/09/23	CI
RootLoc Co., Ltd. announced that it expects to receive KRW 3.686515722 billion in funding from L&K Biomed Ltd.	31/08/23	CI
L&K Biomed to Raise 36.6 Billion Won via Shares Issuance; Shares Plunge 23%	15/05/23	MT
L&K Biomed Ltd.(KOSDAQ:A156100) added to S&P Global BMI Index	20/09/21	CI
L&K Biomed Ltd. announced that it has received KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors	15/07/21	CI
L&K Biomed Ltd. announced that it expects to receive KRW 20 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, BNK Securities Co., Ltd., Investment Arm, Core Trend Investment Ltd., Kiwoom Securities Co., Ltd., Investment Arm and other investors	14/07/21	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	11/09/20	CI
L&K Biomed Ltd.'s Equity Buyback announced on May 30, 2017, has expired with 361,567 shares, representing 3.88% for KRW 2,986.18 million.	10/09/20	CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2020.	28/11/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	29/06/19	CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2019.	30/05/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	30/03/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	04/03/19	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	04/03/19	CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till May 31, 2019.	29/11/18	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	05/09/18	CI
Tranche Update on L&K Biomed Ltd.'s Equity Buyback Plan announced on May 30, 2017.	05/09/18	CI
L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2018.	30/05/18	CI
L&K Biomed Ltd. announced that it expects to receive KRW 16.99996803 billion in funding from ValueSystem Investment Management Corp., Susung Asset Management Co., Ltd., W Asset Management Co., Ltd., Orion Capital Management	24/05/18	CI

L&K BIOMED CO., LTD. is a Korea-based company mainly engaged in the research, development and manufacture of medical devices. The Companyâs products consist of medical devices and medical equipment. Its medical devices include cervical spine products, such as cervical plate systems, cervical screw systems and cervical cage system, as well as thoracolumbar spine products and others. Its medical equipment includes three dimensional (3D) full-body scanners. It also engages in the bio-similar business, which develops cell engineering.

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for L&K Biomed Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
L&K BIOMED LTD.	-0.88%	146M
STRYKER CORPORATION	+14.21%	130B
SMITH & NEPHEW PLC	-3.85%	11.09B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.95%	8.56B
GLAUKOS CORPORATION	+40.43%	5.62B
INSPIRE MEDICAL SYSTEMS, INC.	-27.04%	4.41B
AXONICS, INC.	+7.47%	3.41B
ENOVIS CORPORATION	-15.26%	2.6B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-12.01%	2.07B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.56%	1.92B

Medical Devices & Implants

L&K Biomed Ltd.

Equities

A156100

KR7156100000

Medical Equipment, Supplies & Distribution

L&K Biomed Ltd.'s Equity Buyback Plan Extended till November 30, 2018.

Latest news about L&K Biomed Ltd.

Chart L&K Biomed Ltd.

Company Profile

Income Statement Evolution

Ratings for L&K Biomed Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Medical Devices & Implants